Benjamin E.J. Muntner P. Alonso A. et al.

Heart disease and stroke statistics-2019 update: a report from the american heart association.

Circulation. 139: e56-e528Garcia S. Albaghdadi M.S. Meraj P.M. et al.

Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic.

J Am Coll Cardiol. 75: 2871-2872De Filippo O. D'Ascenzo F. Angelini F. et al.

Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy.

N Engl J Med. 383: 88-89Solomon M.D. McNulty E.J. Rana J.S. et al.

The Covid-19 pandemic and the incidence of acute myocardial infarction.

N Engl J Med. 383: 691-693De Rosa S. Spaccarotella C. Basso C. et al.

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.

Eur Heart J. 41: 2083-2088Mafham M.M. Spata E. Goldacre R. et al.

COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England.

Lancet. 396: 381-389Mohammad M.A. Koul S. Olivecrona G.K. et al.

Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic.

Heart. 106: 1812-1818Xiang D. Xiang X. Zhang W. et al.

Management and outcomes of patients with STEMI during the COVID-19 pandemic in China.

J Am Coll Cardiol. 76: 1318-1324Garcia S. Stanberry L. Schmidt C. et al.

Impact of COVID-19 pandemic on STEMI care: an expanded analysis from the United States.

Catheter Cardiovasc Interv. 98: 217-222Abdelaziz H.K. Abdelrahman A. Nabi A. et al.

Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: insights from a British cardiac center.

Am Heart J. 226: 45-48Lai P.H. Lancet E.A. Weiden M.D. et al.

Characteristics associated with out-of-hospital cardiac arrests and resuscitations during the novel coronavirus disease 2019 pandemic in New York city.

JAMA Cardiol. 5: 1154-1163Riley R.F. Kereiakes D.J. Mahmud E. et al.

Back to the future" for STEMI?: the COVID-19 experience.

JACC Case Rep. 2: 1651-1653Nallamothu B.K. Normand S.L. Wang Y. et al.

Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study.

Lancet. 385: 1114-1122Mahmud E. Dauerman H.L. FGP Welt et al.

Management of acute myocardial infarction during the COVID-19 pandemic: a position statement from the society for cardiovascular angiography and interventions (SCAI), the american college of cardiology (ACC), and the american college of emergency physicians (ACEP).

J Am Coll Cardiol. 76: 1375-1384De Luca G. van 't Hof A.W. de Boer M.J. et al.

Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty.

Eur Heart J. 25: 1009-1013De Luca G. Suryapranata H. Ottervanger J.P. et al.

Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts.

Circulation. 109: 1223-1225Terkelsen C.J. Sørensen J.T. Maeng M. et al.

System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention.

JAMA. 304: 763-771De Luca G. Verdoia M. Cercek M. et al.

Impact of COVID-19 pandemic on mechanical reperfusion for patients with STEMI.

J Am Coll Cardiol. 76: 2321-2330Lechner I. Reindl M. Tiller C. et al.

Impact of COVID-19 pandemic restrictions on ST-elevation myocardial infarction: a cardiac magnetic resonance imaging study.

European Heart Journal. 43: 1141-1153Chew N.W.S. Ow Z.G.W. Teo V.X.Y. et al.

The global effect of the COVID-19 pandemic on STEMI care: a systematic review and meta-analysis.

Can J Cardiol. 37: 1450-1459Keeley E.C. Boura J.A. Grines C.L.

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Lancet. 361: 13-20Jing Z.C. Zhu H.D. Yan X.W. et al.

Recommendations from the peking union medical college hospital for the management of acute myocardial infarction during the COVID-19 outbreak.

Eur Heart J. 41: 1791-1794

Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by 'on the scene' cardiologists.

Eur Heart J. 41: 1788-1790Wang N. Zhang M. Su H. et al.

Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic.

J Int Med Res. 48 ()Stenestrand U. Lindback J. Wallentin L. et al.

Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction.

JAMA. 296: 1749-1756Huynh T. Perron S. O'Loughlin J. et al.

Comparison of primary percutaneous coronary intervention and fibrinolytic therapy in ST-segment-elevation myocardial infarction: bayesian hierarchical meta-analyses of randomized controlled trials and observational studies.

Circulation. 119: 3101-3109St John Sutton M. Lee D. Rouleau J.L. et al.

Left ventricular remodeling and ventricular arrhythmias after myocardial infarction.

Circulation. 107: 2577-2582Araiza-Garaygordobil D. Montalto C. Martinez-Amezcua P. et al.

Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study.

QJM. 114: 642-647Aldujeli A. Hamadeh A. Briedis K. et al.

Delays in Presentation in patients with acute myocardial infarction during the COVID-19 pandemic.

Cardiol Res. 11: 386-391Case B.C. Yerasi C. Wang Y. et al.

Admissions rate and timing of revascularization in the United States in patients with Non-ST-elevation myocardial infarction.

Am J Cardiol. 134: 24-31Li B. Yang J. Zhao F. et al.

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.

Clin Res Cardiol. 109: 531-538Lala A. Johnson K.W. Januzzi J.L. et al.

Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection.

J Am Coll Cardiol. 76: 533-546Zheng Y.Y. Ma Y.T. Zhang J.Y. et al.

COVID-19 and the cardiovascular system.

Nat Rev Cardiol. 17: 259-260Guo T. Fan Y. Chen M. et al.

Cardiovascular implications of fatal outcomes of patients with Coronavirus disease 2019 (COVID-19).

JAMA Cardiol. 5: 811-818Madjid M. Safavi-Naeini P. Solomon S.D. et al.

Potential Effects of coronaviruses on the cardiovascular system: a review.

JAMA Cardiol. 5: 831-840Lodigiani C. Iapichino G. Carenzo L. et al.

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.

Thromb Res. 191: 9-14Bilaloglu S. Aphinyanaphongs Y. Jones S. et al.

Thrombosis in hospitalized patients with COVID-19 in a New York City health system.

JAMA. 324: 799-801Modin D. Claggett B. Sindet-Pedersen C. et al.

Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction.

Circulation. 142: 2080-2082Katsoularis I. Fonseca-Rodriguez O. Farrington P. et al.

Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study.

Lancet. 398: 599-607

COVID-19 update: covid-19-associated coagulopathy.

J Thromb Thrombolysis. 50: 54-67Abizaid A. Campos C.M. Guimaraes P.O. et al.

Patients with COVID-19 who experience a myocardial infarction have complex coronary morphology and high in-hospital mortality: primary results of a nationwide angiographic study.

Catheter Cardiovasc Interv. 98: E370-E378Garcia S. Dehghani P. Grines C. et al.

Initial findings from the North American COVID-19 myocardial infarction registry.

J Am Coll Cardiol. 77: 1994-2003Skulstad H. Cosyns B. Popescu B.A. et al.

COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel.

Eur Heart J Cardiovasc Imaging. 21: 592-598Henry T.D. Kereiakes D.J.

The direct and indirect effects of the COVID-19 pandemic on cardiovascular disease throughout the world.

Eur Heart J. : ehab782

American heart association's mission L, get with the guidelines coronary artery disease advisory work G, the council on clinical cardiology's committees on acute cardiac C, general C, interventional cardiovascular C. Temporary emergency guidance to STEMI systems of care during the COVID-19 pandemic: AHA's mission: lifeline.

Circulation. 142: 199-202Sofi F. Dinu M. Reboldi G. et al.

Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: a systematic review and meta-analysis.

Int J Cardiol. 347: 89-96